Health Care Workers Cohort Study in the EuCARE Project (EuCARE-HCW)
Launched by EURESIST NETWORK GEIE · Sep 6, 2022
Trial Information
Current as of June 29, 2025
Recruiting
Keywords
ClinConnect Summary
The EuCARE-HCW study is looking at how COVID-19 affects healthcare workers, specifically focusing on their vaccination and infection history. This research involves gathering information and samples from healthcare workers across eight countries, including Portugal, Italy, and Mexico. The goal is to understand how different variants of the virus might impact the body’s immune response, including how well vaccines work against these variants.
If you're a healthcare worker aged 18 or older and have information about your COVID-19 vaccination and infection history, you may be eligible to participate in this study. There are no specific exclusions, so most healthcare workers can join. Participants will provide samples and information that will help researchers analyze how the virus and vaccines interact. Your involvement could contribute valuable insights into improving COVID-19 responses in the healthcare community.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- The study subjects will be selected based on the following inclusion criteria:
- • 1. Adult (\>18 years) HCW with mandatory information on their SARS-CoV-2 infection and vaccination status.
- • 2. For those with a history of SARS-CoV-2 infection, diagnosis obtained by detection of SARS-CoV-2 RNA
- • 3. Having a signed informed consent when required by ethical approval
- • Exclusion Criteria: NONE
About Euresist Network Geie
Euresist Network GEIE is a collaborative research initiative focused on advancing the understanding and management of antibiotic resistance in healthcare settings. Comprising a consortium of academic institutions, healthcare providers, and industry partners, Euresist aims to facilitate innovative clinical trials and studies that explore the efficacy of novel therapeutic approaches and preventive strategies against resistant infections. By leveraging a multidisciplinary approach, the network strives to enhance patient outcomes, inform public health policies, and contribute to the global effort in combating antimicrobial resistance.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Düsseldorf, , Germany
Hanoi, , Vietnam
Lisbon, , Portugal
Milan, , Italy
Milan, , Italy
Vilnius, , Lithuania
Villahermosa, , Mexico
Patients applied
Trial Officials
CRISTINA TOSCANO, DR
Study Chair
Centro Hospitalar de Lisboa Ocidental (CHLO)
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials